These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15983260)

  • 21. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
    Hernández-Vargas P; Ortiz-Muñoz G; López-Franco O; Suzuki Y; Gallego-Delgado J; Sanjuán G; Lázaro A; López-Parra V; Ortega L; Egido J; Gómez-Guerrero C
    Circ Res; 2006 Nov; 99(11):1188-96. PubMed ID: 17053192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of hedgehog signalling in ApoE - /- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophages.
    Beckers L; Heeneman S; Wang L; Burkly LC; Rousch MM; Davidson NO; Gijbels MJ; de Winther MP; Daemen MJ; Lutgens E
    J Pathol; 2007 Aug; 212(4):420-8. PubMed ID: 17573667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.
    Kato R; Mori C; Kitazato K; Arata S; Obama T; Mori M; Takahashi K; Aiuchi T; Takano T; Itabe H
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):33-9. PubMed ID: 18988894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic retinoid Am80 reduces scavenger receptor expression and atherosclerosis in mice by inhibiting IL-6.
    Takeda N; Manabe I; Shindo T; Iwata H; Iimuro S; Kagechika H; Shudo K; Nagai R
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1177-83. PubMed ID: 16484594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I.
    Seetharam D; Mineo C; Gormley AK; Gibson LL; Vongpatanasin W; Chambliss KL; Hahner LD; Cummings ML; Kitchens RL; Marcel YL; Rader DJ; Shaul PW
    Circ Res; 2006 Jan; 98(1):63-72. PubMed ID: 16339487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis.
    Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R
    J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of evidence for antiatherogenic effects of wheat bran or corn bran in apolipoprotein E-knockout mice.
    Zhao Z; Xu Z; Le K; Azordegan N; Riediger ND; Moghadasian MH
    J Agric Food Chem; 2009 Jul; 57(14):6455-60. PubMed ID: 19601675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
    Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Véniant MM
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
    Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
    Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
    Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
    Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Hu Q; Zhang XJ; Liu CX; Wang XP; Zhang Y
    J Vasc Res; 2010; 47(1):69-79. PubMed ID: 19729954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current world literature.
    Curr Opin Lipidol; 2011 Aug; 22(4):308-10. PubMed ID: 21743305
    [No Abstract]   [Full Text] [Related]  

  • 35. [The importance of apolipoproteins in dyslipidemias].
    Quintão EC
    Arq Bras Cardiol; 1988 Feb; 50(2):129-34. PubMed ID: 3063237
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis on lipid metabolism and atherogenesis by transgenic technology].
    Shimano H
    Tanpakushitsu Kakusan Koso; 1994 Oct; 39(13):2211-21. PubMed ID: 7972869
    [No Abstract]   [Full Text] [Related]  

  • 37. [Apolipoprotein E as a risk factor of coronary arteriosclerosis].
    Titov VN; Nikitin SV; Tvorogova MG
    Kardiologiia; 1991 Jul; 31(7):71-4. PubMed ID: 1779525
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dyslipidemias or dyslipoproteinemias? How can one detect the etiology of lipid metabolism disorders in subjects disposed to coronary accidents?].
    Vastesaeger E; Vastesaeger M
    Brux Med; 1968 Oct; 48(10):655-60. PubMed ID: 5757970
    [No Abstract]   [Full Text] [Related]  

  • 39. A genetic variant of the scavenger receptor BI in humans.
    Khovidhunkit W
    N Engl J Med; 2011 Apr; 364(14):1375-6; author reply 1376. PubMed ID: 21470028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Animal models of hypercholesterolemia: transgenic mouse/rabbit].
    Fan J; Watanabe T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():621-5. PubMed ID: 11351661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.